检索结果-南通市图书馆

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2023年第3期10卷 281-298页

作者： Fei Pei Ren‑Qi Yao Chao Ren Soheyl Bahrami Timothy RBilliar Irshad HChaudry De‑Chang Chen Xu‑Lin Chen Na Cui Xiang‑Ming Fang Yan Kang Wei‑Qin Li Wen‑Xiong Li Hua‑Ping Liang Hong‑Yuan Lin Ke‑Xuan Liu Ben Lu Zhong‑Qiu Lu Marc Maegele Tian‑Qing Peng You Shang Lei Su Bing‑Wei Sun Chang‑Song Wang Jian Wang Jiang‑Huai Wang Ping Wang Jian‑Feng Xie Li‑Xin Xie Li‑Na Zhang Basilia Zingarelli Xiang‑Dong Guan Jian‑Feng Wu Yong‑Ming Yao department of Critical Care Medicine the First Affiliated Hospital of Sun Yat-Sen University58 Zhongshan Er RoadYuexiu DistrictGuangzhou 510080GuangdongChina Translational Medicine Research Center Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital28 Fuxing RoadHaidian DistrictBeijing 100853China department of Burn Surgery the First Affiliated Hospital of Naval Medical UniversityShanghai 200433China Ludwig-Boltzmann Institute for Experimental and Clinical Traumatology 1200 ViennaAustria department of Surgery University of Pittsburgh Medical CenterPittsburghPA 15213USA Center for Surgical Research and department of Surgery University of Alabama at BirminghamBirminghamAL 35294USA department of Critical Care Medicine Ruijin HospitalShanghai Jiaotong UniversityShanghai 200025China department of Burns the First Affiliated Hospital of Anhui Medical UniversityHefei 230022China department of Critical Care Medicine Peking Union Medical College HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100730China department of Anesthesiology the First Affiliated HospitalZhejiang University School of MedicineHangzhou 31003China department of Critical Care Medicine West China Hospital of Sichuan UniversityChengdu 610041China department of Critical Care Medicine General Hospital of Eastern Theater Command of Chinese PLANanjing 210002China department of Surgical Intensive Critical Unit Beijing Chao‑Yang HospitalCapital Medical UniversityBeijing 100020China State Key Laboratory of Trauma Burns and Combined InjuryResearch Institute of SurgeryDaping HospitalArmy Medical UniversityChongqing 400042China department of Critical Care Medicine Fourth Medical Center of the Chinese PLA General HospitalBeijing 100048China department of Anesthesiology Nanfang HospitalSouthern Medical UniversityGuangzhou 510515China department of Critical Care Medicine and Hematology the Third Xiangya HospitalCentral South UniversityChangs

Emerged evidence has indicated that immunosuppression is involved in the occurrence and development of *** provide clinical practice recommendations on the immune function in sepsis,an expert consensus focusing on the monitoring and treatment of sepsis-induced immunosuppression was *** related to the immune monitoring and treatment of sepsis were retrieved from PubMed,Web of Science,and Chinese National Knowledge Infrastructure to design items and expert opinions were collected through an online ***,the Delphi method was used to form consensus opinions,and RAND appropriateness method was developed to provide consistency evaluation and recommendation levels for consensus *** consensus achieved satisfactory results through two rounds of questionnaire survey,with 2.statements rated as perfect consistency,13 as very good consistency,and 9 as good *** summarizing the results,a total of 14 strong recommended opinions,8 weak recommended opinions and 2.non-recommended opinions were ***,a face-to-face discussion of the consensus opinions was performed through an online meeting,and all judges unanimously agreed on the content of this *** summary,this expert consensus provides a preliminary guidance for the monitoring and treatment of immunosuppression in patients with sepsis.

关键词： Sepsis Immune function monitoring Immunomodulatory therapy Immunosuppression

非小细胞肺癌融合基因检测临床实践中国专家共识(2.2.版)

在线全文

学校读者我要写书评

暂无评论

中华病理学杂志 2023年第6期52卷 565-573页

作者：中国抗癌协会肿瘤病理专业委员会中华医学会肿瘤学分会肺癌专家委员会国家病理质控中心李卫华李子明应建明陆舜梁智勇不详国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院、北京协和医学院肿瘤医院病理科北京100021 上海市胸科医院上海交通大学附属胸科医院肿瘤科上海200030 中国医学科学院北京协和医学院北京协和医院病理科北京100730

基因融合是非小细胞肺癌中一类重要的分子变异。近十余年来,针对融合基因的靶向治疗进展迅速,为特定融合基因阳性患者带来显著临床获益。然而,基因融合形成机制多样,检测方法众多,不同方法各有优缺点,在临床分子检测中相对复杂。本文旨... 详细信息

基因融合是非小细胞肺癌中一类重要的分子变异。近十余年来,针对融合基因的靶向治疗进展迅速,为特定融合基因阳性患者带来显著临床获益。然而,基因融合形成机制多样,检测方法众多,不同方法各有优缺点,在临床分子检测中相对复杂。本文旨在从融合基因检测的临床意义、适用人群、常见融合基因的共性和特性、常用检测方法优缺点和检测策略优化等多个角度出发,基于国内外临床检测实践,达成非小细胞肺癌融合基因检测的中国专家共识,以规范融合基因的分子检测,精准筛选适合特定靶向治疗的患者人群。

关键词：非小细胞肺癌靶向治疗中国专家共识基因融合临床实践适用人群分子检测融合基因

在线全文

学校读者我要写书评

暂无评论

中国人群肝癌筛查指南(2.2.,北京)

中华消化外科杂志 2022年第8期21卷 971-996页

作者：赫捷陈万青沈洪兵李霓曲春枫石菊芳孙凤姜晶曹广文庄贵华彭绩中国人群肝癌筛查指南制定专家组中国人群肝癌筛查指南制定工作组国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院北京100021 南京医科大学公共卫生学院肿瘤个体化医学省部共建协同创新中心南京211166 北京大学公共卫生学院北京100191 吉林大学第一医院长春130021 海军军医大学流行病学教研室上海200433 西安交通大学医学部公共卫生学院西安710061 深圳市慢性病防治中心深圳518020 不详

中国人群的肝癌存在生存率低、死亡率高的情况,如何有效降低肝癌相关负担仍是中国公共卫生和慢性病防控领域亟待解决的重大问题,而肝癌人群筛查策略优化是值得持续探索的重要抓手和方向。《中国人群肝癌筛查指南(2.2.,北京)》受国家卫... 详细信息

中国人群的肝癌存在生存率低、死亡率高的情况,如何有效降低肝癌相关负担仍是中国公共卫生和慢性病防控领域亟待解决的重大问题,而肝癌人群筛查策略优化是值得持续探索的重要抓手和方向。《中国人群肝癌筛查指南(2.2.,北京)》受国家卫生健康委员会疾病预防控制局委托,由国家癌症中心发起,联合多学科专家,根据世界卫生组织推荐的指南制定原则和方法,整合肝癌人群筛查领域的国内外研究新证据,兼顾中国国情及实践经验,针对肝癌筛查过程中的筛查人群、筛查技术、监测方案等呈现循证推荐,以期为中国人群肝癌筛查实践的规范提供参考。

关键词：肝肿瘤筛查监测指南中国

骨肿瘤病理标本处理、取材和规范化病理报告临床实践指南(2.2.版)

在线全文

学校读者我要写书评

暂无评论

中华病理学杂志 2023年第11期52卷 1098-1106页

作者：中华医学会病理学分会中国抗癌协会肿瘤病理专业委员会中国抗癌协会肉瘤专业委员会中国临床肿瘤学会肉瘤专业委员会病理学组中国研究型医院学会病理学专业委员会《骨肿瘤病理标本处理、取材和规范化病理报告临床实践指南(版)》编写专家委员会宫丽华黄瑾刘绮颖王卓丁宜张惠箴李扬王坚不详首都医科大学附属北京积水潭医院病理科、北京大学第四临床医学院、国家骨科医学中心北京100035 上海交通大学医学院附属第六人民医院病理科、国家骨科医学中心上海200233 复旦大学附属肿瘤医院病理科、复旦大学上海医学院肿瘤学系、复旦大学病理研究所上海200032 中山大学附属第一医院病理科、中山大学中山医学院病理学教研室广州510080

骨肿瘤的标本处理、取材对整合性病理诊断至关重要,规范化的病理报告则为临床治疗、疗效评判和预后评估提供可靠的病理依据。《骨肿瘤病理标本处理、取材和规范化病理报告临床实践指南(2.2.版)》编写专家委员会组织专家撰写本指南,旨在... 详细信息

骨肿瘤的标本处理、取材对整合性病理诊断至关重要,规范化的病理报告则为临床治疗、疗效评判和预后评估提供可靠的病理依据。《骨肿瘤病理标本处理、取材和规范化病理报告临床实践指南(2.2.版)》编写专家委员会组织专家撰写本指南,旨在指导和规范上述工作流程,以期提升诊断质量并更好地服务于临床。

关键词：临床实践指南诊断质量病理报告标本处理病理诊断骨肿瘤预后评估规范化

Short-term and oncological outcomes of natural orifice specimen extraction surgery(NOSES)for colorectal cancer in china:a national database study of 5055 patients

在线全文

学校读者我要写书评

暂无评论

Science Bulletin 2022年第13期67卷 1331-1334,M0003页

作者： Xu Guan Xiyue Hu Zheng Jiang Ye Wei Donghui Sun Miao Wu Haitao Zhou Hongliang Yao Junmin Song Guiyu Wang Junhong Hu Mingyang Ren Qing Xu Jianchun Cai Jian Peng Dan Ma Yangchun Zheng Qingsi He Bo Jiang Zejun Wang Taiyuan Li Su Yan Luchuan Chen Tiegang Li Zhiguo Xiong Pan Chi Liang Kang Gang Yu Xiaodong Deng Hong Zhang Ming Xie Jianbao Wei Hongyan Gong Xuejun Sun Weidong Zang Yongmao Song Peng He Zhengqi Wen Chunxu Zhang Yusheng Wang Yinggang Chen Guangwei Xie Mingzhang Li Shaojun Yu Haiying Liu Min Pu Chuangang Fu Xishan Wang on behalf of china NOSES Alliance department of Colorectal Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China department of General Surgery Zhongshan HospitalFudan UniversityShanghai 200032China department of Gastrointestinal and Anal Surgery Jilin University First HospitalChangchun 130021China department of Gastrointestinal Surgery The Second People’s Hospital of YibinYibin 644000China department of Gastrointestinal Surgery The Second Xiangya HospitalCentral South UniversityChangsha 410011China department of Anorectal Surgery First Affiliated HospitalZhengzhou UniversityZhengzhou 450052China department of Colorectal Cancer Surgery The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150081China department of Gastrointestinal Surgery Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000China department of Gastrointestinal Surgery Renji HospitalShanghai JiaoTong University School of MedicineShanghai 200240China department of Gastrointestinal Surgery Zhongshan Hospital of Xiamen UniversityXiamen 361004China department of General Surgery Xiangya HospitalCentral South UniversityChangsha 410008China department of General Surgery Xinqiao HospitalThird Military Medical UniversityChongqing 400037China department of Gastrointestinal Surgery Sichuan Cancer HospitalChengdu 610041China department of General Surgery Shandong University Qilu HospitalJinan 250012China department of Colorectal and Anal Surgery Shanxi Cancer HospitalTaiyuan 030013China department of Gastrointestinal Surgery The Affiliated Cancer Hospital of Guizhou Medical UniversityGuiyang 550008China department of General Surgery The First Affiliated Hospital of Nanchang UniversityNanchang 330006China department of Gastrointestinal Surgery Qinghai University Affiliated HospitalXining 810012China department of Gastrointestinal Surgery Fujian Medical University Cancer HospitalFuzhou 350014China Depar

经自然腔道取标本手术(NOSES)通过无切口理念与常规手术器械的结合,表现出极佳的微创效果,并带给患者全新的就医感受.目前,尽管NOSES已广泛用于结直肠肿瘤治疗,大量研究也表明相比常规腹腔镜手术,NOSES具有恢复快、创伤小、疼痛轻等优势... 详细信息

经自然腔道取标本手术(NOSES)通过无切口理念与常规手术器械的结合,表现出极佳的微创效果,并带给患者全新的就医感受.目前,尽管NOSES已广泛用于结直肠肿瘤治疗,大量研究也表明相比常规腹腔镜手术,NOSES具有恢复快、创伤小、疼痛轻等优势,但绝大多数研究均为小样本、单中心回顾性研究.本研究旨在通过分析我国5055例结直肠肿瘤NOSES患者数据,进一步探讨NOSES的短期疗效与预后.研究对象中,经直肠NOSES占整体比例的90.3%,经阴道NOSES占9.7%.NOSES术后短期并发症发生率为14.1%,吻合口瘘发生率为4.9%,腹盆腔感染率为1.9%.患者3年总生存率为93.2.,无病生存率为82.2.,局部复发率为3.6%.研究结果提示NOSES具有较好的安全性与可行性,为其应用于结直肠肿瘤治疗提供了证据.

关键词：结直肠肿瘤肿瘤学并发症发生率无病生存率吻合口瘘回顾性研究总生存率经直肠

非小细胞肺癌分子病理检测临床实践指南(2.2.版)

在线全文

学校读者我要写书评

暂无评论

中华病理学杂志 2021年第4期50卷 323-332页

作者：中华医学会病理学分会国家病理质控中心中华医学会肿瘤学分会肺癌学组中国抗癌协会肺癌专业委员会中国胸部肿瘤研究协作组应建明师晓华梁智勇吴一龙陆舜不详国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院病理科 100021 中国医学科学院北京协和医学院北京协和医院病理科 100730 中国医学科学院北京协和医学院北京协和医院病理科100730 广东省人民医院广东省肺癌研究所广州510080 上海市胸科医院上海交通大学附属胸科医院肿瘤科 200030

近十年来,晚期非小细胞肺癌的治疗,尤其是靶向治疗,取得了极大的进展,分子分型是非小细胞肺癌实施靶向治疗的前提。选择准确、快速、恰当的检测方法,全面筛选出适用靶向药物的目标人群具有重要临床意义。本指南基于国内临床实践数据及... 详细信息

近十年来,晚期非小细胞肺癌的治疗,尤其是靶向治疗,取得了极大的进展,分子分型是非小细胞肺癌实施靶向治疗的前提。选择准确、快速、恰当的检测方法,全面筛选出适用靶向药物的目标人群具有重要临床意义。本指南基于国内临床实践数据及结合中国国情,以国内已上市治疗药物及体外诊断检测试剂为导向制定,重在对分子病理检测实践的指导。其他靶基因及免疫治疗相关生物标志物只做简单概述,待更多实践数据的积累后更新。

关键词：体外诊断临床实践指南非小细胞肺癌目标人群分子病理检测靶向治疗免疫治疗靶向药物

Consensus on the Diagnosis and Treatment of Melasma in china (2.2. Version)

在线全文

学校读者我要写书评

暂无评论

International Journal of Dermatology and Venereology 2021年第3期4卷 133-139页

作者： Pigmentary Disorder Group,Combination of Traditional and Western Medicine Dermatology Research Center for Vitiligo,Chinese Society of Dermatology Working Group on Pigmentary Disorders,china Dermatologist Association Tian-Wen Gao Hua Gu Li He Tie-Chi Lei Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Cai-Xia Tu Hai Wen Ji-Yuan Wu Ai-E Xu Jun-Ling Zhang Zhi-Zhong Zhen 不详 department of Dermatology Xijing HospitalThe Fourth Military Medical UniversityXi’anShanxi 710032China department of Dermatology The First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Renmin Hospital of Wuhan university WuhanHubei 430000China department of Dermatology Zhongshan Hospital of Fudan UniversityShanghai 200000China department of Dermatology The 7th Municipal People’s Hospital in ShenyangShenyangLiaoning 110000China Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical Sciences and Peking Union Medical CollegeNanjingJiangsu 210000China department of Dermatology The First Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShanxi 710032China department of Dermatology The Second Affiliated Hospital of Dalian Medical UniversityShenyangDalian 116000China department of Dermatology Changzheng Hospital of Navy Medical UniversityShanghai 200000China department of Dermatology The First Hospital of Wuhan CityWuhanHubei 430000China department of Dermatology The Third People’s Hospital of HangzhouHangzhouZhejiang 310000China The Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine Tianjing 300000China department of Dermatology Huashan Hospital of Fudan UniversityShanghai 20000China

The pathogenesis of melasma is believed to be related to heredity,sun exposure,sex hormones,and other *** mechanisms underlying the development of melasma include increased melanin synthesis,vascular proliferation within the skin lesions,inflammation,and skin barrier *** diagnosis of melasma is mainly based on clinical manifestations and noninvasive *** with recent research progress in melasma,the present consensus comprehensively elaborates the etiology,pathogenesis,clinical manifestations,staging,classification,diagnosis,and treatment of melasma to improve the diagnostic and therapeutic skills of Chinese dermatologists.

关键词： diagnosis expert consensus melasma therapy

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

非小细胞肺癌MET临床检测中国专家共识

中华病理学杂志 2022年第11期51卷 1094-1103页

作者：中华医学会病理学分会国家病理质控中心中华医学会肿瘤学分会肺癌学组中国抗癌协会肺癌专业委员会中国胸部肿瘤研究协作组周晓燕梁智勇陆舜吴一龙不详复旦大学附属肿瘤医院病理科上海200032 中国医学科学院北京协和医学院北京协和医院病理科北京100730 上海交通大学附属胸科医院肿瘤科上海200030 广东省人民医院广东省肺癌研究所广州510080

非小细胞肺癌(non-small cell lung cancer,NSCLC)中MET异常(MET alteration)包括MET基因第14号外显子跳跃突变(MET 14跳突)、MET基因扩增、MET基因点突变(主要是激酶区突变)、MET基因融合及MET蛋白过表达等。NSCLC患者中MET 14跳突的... 详细信息

非小细胞肺癌(non-small cell lung cancer,NSCLC)中MET异常(MET alteration)包括MET基因第14号外显子跳跃突变(MET 14跳突)、MET基因扩增、MET基因点突变(主要是激酶区突变)、MET基因融合及MET蛋白过表达等。NSCLC患者中MET 14跳突的发生率为0.9%~4.0%,目前国内外已有针对MET 14跳突的靶向药物获批上市,晚期NSCLC患者应进行包含MET 14跳突的检测以筛选MET抑制剂靶向治疗获益人群;原发MET基因扩增在NSCLC患者中的发生率为1%~5%,继发MET基因扩增在表皮生长因子受体酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)耐药患者中发生率为5%~50%,在间变性淋巴瘤激酶TKI耐药患者中发生率约为13%;MET蛋白过表达在NSCLC患者的发生率为13.7%~63.7%。关于MET基因扩增和MET蛋白过表达的多项临床试验正在进行中,显示出其在MET抑制剂临床治疗中作为生物标志物具有重要指导价值。准确检测MET异常是实施MET抑制剂治疗的前提,因MET异常形式和检测方法多,临床检测中面临的问题和挑战多,故需进一步梳理和规范。本编写组结合临床实践经验、文献阅读并组织专家讨论,针对MET异常的3种主要类型(MET 14跳突、MET基因扩增和MET蛋白过表达)制定了本共识,以期指导临床MET检测的实践。

关键词：间变性淋巴瘤激酶非小细胞肺癌基因扩增临床试验临床检测靶向治疗文献阅读基因融合

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia(2.2. Edition)

在线全文

学校读者我要写书评

暂无评论

Military Medical Research 2022年第5期9卷 515-533页

作者： Xian-Tao Zeng Ying-Hui Jin Tong-Zu Liu Fang-Ming Chen De-Gang Ding Meng Fu Xin-Quan Gu Bang-Min Han Xing Huang Zhi Hou Wan-Li Hu Xin-Li Kang Gong-Hui Li Jian-Xing Li Pei-Jun Li Chao-Zhao Liang Xiu-Heng Liu Zhi-Yu Liu Chun-Xiao Liu Jiu-Min Liu Guang-Heng Luo Yi Luo Wei-Jun Qin Jian-Hong Qiu Jian-Xin Qiu Xue-Jun Shang Ben-Kang Shi Fa Sun Guo-Xiang Tian Ye Tian Feng Wang Feng Wang Yin-Huai Wang Yu-Jie Wang Zhi-Ping Wang Zhong Wang Qiang Wei Min-Hui Xiao Wan-Hai Xu Fa-Xian Yi Chao-Yang Zhu Qian-Yuan Zhuang Li-Qun Zhou Xiao-Feng Zou Nian-Zeng Xing Da-Lin He Xing-Huan Wang 无 department of Urology Institute of UrologyZhongnan Hospital of Wuhan UniversityWuhan430071China Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan430071China department of Urology Tianjin Third Central Hospital Affiliated To Nankai UniversityTianjin300170China department of Urology Henan Provincial People’s HospitalZhengzhou University People’s HospitalZhengzhou450003China department of Urology Beijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijing102218China department of Urology China-Japan Union Hospital of Jilin UniversityChangchun130033China department of Urology Shanghai General HospitalShanghai Jiao Tong University School of MedicineShanghai200080China department of Urology Qinghai University Affiliated HospitalXi’ning810012China department of Urology People’s Hospital of Hainan ProvinceHainan Affiliated Hospital of Hainan Medical University HaikouHaikou570311China department of Urology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou310016China department of Urology General Hospital of Ningxia Medical UniversityYinchuan750003China department of Urology The First Affiliated Hospital of Anhui Medical UniversityHefei230022China department of Urology Renmin Hospital of Wuhan UniversityWuhan430060China department of Urology The Second Hospital of Dalian Medical UniversityDalian116023LiaoningChina department of Urology Zhujiang Hospital of Southern Medical UniversityGuangzhou510282China department of Urology Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou510080China department of Urology Surgery Guizhou Province People’s HospitalGuiyang550002China department of Urology Xijing Hospital of Air Force Military Medical UniversityXi’an710032China department of Urology The 980St Hospital of the PLA Joint Logistics Support Force(Bethune International Peace Hospital of PLA)Shijiazhuang050082China department of Urology

Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2.18, we issued the guideline “2.18 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 2. carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different

关键词： Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Recommendation Treatment Guideline